Last update 21 Nov 2024
BZ-019(Shanghai Cell Therapy Group Co. Ltd.)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms CD19 pbCAR-T + [1] |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with BZ-019(Shanghai Cell Therapy Group Co. Ltd.)A Phase II Clinical Study of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells Injection, for Relapsed and Refractory (R/R) Large B-cell Lymphoma
靶向CD19自体嵌合抗原受体T细胞注射液治疗复发或难治性大B细胞淋巴瘤的I期临床研究
[Translation] Phase I clinical study of CD19-targeted autologous chimeric antigen receptor T cell injection in the treatment of relapsed or refractory large B-cell lymphoma
A Phase I Clinical Study of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells Injection, for Relapsed and Refractory (R/R) Large B-cell Lymphoma
100 Clinical Results associated with BZ-019(Shanghai Cell Therapy Group Co. Ltd.)
Login to view more data
100 Translational Medicine associated with BZ-019(Shanghai Cell Therapy Group Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with BZ-019(Shanghai Cell Therapy Group Co. Ltd.)
Login to view more data
100 Deals associated with BZ-019(Shanghai Cell Therapy Group Co. Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Large B-cell lymphoma | Phase 2 | CN | 04 Jun 2021 | |
| CD19 positive Non-Hodgkin Lymphoma | Phase 2 | CN | 14 Jun 2018 | |
| High grade B-cell lymphoma | Phase 2 | CN | 14 Jun 2018 | |
| Mediastinal large B-cell lymphoma | Phase 2 | CN | 14 Jun 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free